Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Moran, C.J.
Right arrow Articles by Morrison, J.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moran, C.J.
Right arrow Articles by Morrison, J.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 8, No. 2, 196-200, February 2002
© 2002 European Society of Human Reproduction and Embryology


Implantation and pregnancy

Expression and modulation of Rho kinase in human pregnant myometrium

C.J. Moran1, A.M. Friel1,2, T.J. Smith2, M. Cairns2 and J.J. Morrison1

1 Department of Obstetrics and Gynaecology, National University of Ireland Galway, Clinical Science Institute, University College Hospital, Newcastle Road, Galway and 2 National Diagnostics Centre, BioResearch Ireland, National University of Ireland Galway, University Road, Galway, Ireland

There is little information outlining the role of Rho kinase, RhoA, and calcium sensitization in regulation of human uterine contractility during pregnancy. The aims of this study were to investigate the expression of RhoA, and the Rho kinases ROCK I and ROCK II in human pregnant myometrium, to evaluate the effects of Rho kinase inhibition on pregnant human myometrial contractility in vitro, and to compare these effects with those of the calcium channel blocker nifedipine. RT–PCR using primers for RhoA, ROCK I and ROCK II was performed on mRNA isolated from human pregnant myometrium. Isometric recording was performed in isolated myometrial strips obtained at Caesarean section. The effects of the Rho kinase inhibitor Y-27632 (1 nmol/l to 10 mmol/l), and nifedipine (1 nmol/l to 10 mmol/l), on oxytocin (0.5 nmol/l) induced contractions were measured and compared. Expression of RhoA, ROCK I and ROCK II mRNA was identified in human pregnant myometrium (n = 3). Y-27632 exerted a potent relaxant effect on myometrial contractility with a pD2 value (± SEM) of 7.63 ± 0.38 (n = 6). The maximum net relaxant effect (± SEM) was 72.3 ± 6.1% (n = 6). Corresponding values for nifedipine were 7.24 ± 0.48 (n = 6; P = 0.469) and 93.40 ± 3.1% (n = 6; P = 0.028). Rho A/Rho kinase-mediated calcium sensitization may play role in the physiology of human parturition, and pharmacological inhibition of this pathway may therefore provide a novel approach to tocolysis for pre-term labour.

human myometrium/preterm labour/Rho kinase/tocolysis

3 To whom correspondence should be addressed. E-mail: john.morrison{at}nuigalway.ie


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
J Lartey and A Lopez Bernal
RHO protein regulation of contraction in the human uterus
Reproduction, September 1, 2009; 138(3): 407 - 424.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D. P Fischer, J. A Hutchinson, D. Farrar, P. J O'Donovan, D. F Woodward, and K. M Marshall
Loss of prostaglandin F2{alpha}, but not thromboxane, responsiveness in pregnant human myometrium during labour
J. Endocrinol., April 1, 2008; 197(1): 171 - 179.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. M. Friel, P. G. Hynes, D. J. Sexton, T. J. Smith, and J. J. Morrison
Expression Levels of mRNA for Rho A/Rho Kinase and Its Role in Isoprostane-Induced Vasoconstriction of Human Placental and Maternal Vessels
Reproductive Sciences, February 1, 2008; 15(2): 179 - 188.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
J. Lartey, M. Smith, J. Pawade, B. Strachan, H. Mellor, and A. L. Bernal
Up-Regulation of Myometrial RHO Effector Proteins (PKN1 and DIAPH1) and CPI-17 (PPP1R14A) Phosphorylation in Human Pregnancy Is Associated with Increased GTP-RHOA in Spontaneous Preterm Labor
Biol Reprod, June 1, 2007; 76(6): 971 - 982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Kawamata, Y. Tonomura, T. Kimura, Y. Sugimoto, T. Yanagisawa, and K. Nishimori
Oxytocin-induced phasic and tonic contractions are modulated by the contractile machinery rather than the quantity of oxytocin receptor
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E992 - E999.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Shimizu, M. Tahara, S. Ogata, K. Hashimoto, K. Morishige, K. Tasaka, and Y. Murata
Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells
Mol. Hum. Reprod., March 1, 2007; 13(3): 181 - 187*.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Smith
Parturition
N. Engl. J. Med., January 18, 2007; 356(3): 271 - 283.
[Full Text] [PDF]


Home page
ReproductionHome page
A. M Friel, D. J Sexton, M. W O'Reilly, T. J Smith, and J. J Morrison
Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction
Reproduction, July 1, 2006; 132(1): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. M. Friel, M. Curley, N. Ravikumar, T. J. Smith, and J. J. Morrison
Rho A/Rho Kinase mRNA and Protein Levels in Human Myometrium During Pregnancy and Labor
Reproductive Sciences, January 1, 2005; 12(1): 20 - 27.
[Abstract] [PDF]


Home page
EndocrinologyHome page
E. Karteris, E. W. Hillhouse, and D. Grammatopoulos
Urocortin II Is Expressed in Human Pregnant Myometrial Cells and Regulates Myosin Light Chain Phosphorylation: Potential Role of the Type-2 Corticotropin-Releasing Hormone Receptor in the Control of Myometrial Contractility
Endocrinology, February 1, 2004; 145(2): 890 - 900.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C Cario-Toumaniantz, G Reillaudoux, V Sauzeau, F Heutte, N Vaillant, M Finet, P Chardin, G Loirand, and P Pacaud
Modulation of RhoA--Rho kinase-mediated Ca2+ sensitization of rabbit myometrium during pregnancy -- role of Rnd3
J. Physiol., October 15, 2003; 552(2): 403 - 413.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Wrayzx, K. Jones, S. Kupittayanant, Y. Li, A. Matthew, E. Monir-Bishty, K. Noble, S. J. Pierce, S. Quenby, and A. V. Shmygol
Calcium Signaling and Uterine Contractility
Reproductive Sciences, July 1, 2003; 10(5): 252 - 264.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.